Skip to main content
logo
Amplia Therapeutics Limited (ASX:ATX)
Australia flag Australia · Delayed Price · Currency is AUD
0.2350
-0.0050 (-2.08%)
At close: Mar 31, 2026

Amplia Therapeutics Income Statement

Millions AUD. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Other Revenue
5.013.784.451.191.981.53
Revenue
5.013.784.451.191.981.53
Revenue Growth (YoY)
46.79%-15.02%274.34%-40.02%29.33%4380.44%
Cost of Revenue
0.30.210.440.310.150.31
Gross Profit
4.713.574.010.881.831.22
Selling, General & Admin
3.162.672.62.21.641.13
Research & Development
9.737.535.84.693.772.21
Operating Expenses
13.0310.378.587.175.473.56
Operating Income
-8.32-6.79-4.57-6.29-3.64-2.34
Interest Expense
-0.01-0.06-0.08-0.05-0-
Interest & Investment Income
0.40.280.150.100
EBT Excluding Unusual Items
-7.93-6.57-4.5-6.24-3.64-2.34
Other Unusual Items
-----0.06
Pretax Income
-7.93-6.57-4.5-6.24-3.64-2.28
Net Income
-7.93-6.57-4.5-6.24-3.64-2.28
Net Income to Common
-7.93-6.57-4.5-6.24-3.64-2.28
Shares Outstanding (Basic)
39430719419414695
Shares Outstanding (Diluted)
39430719419414695
Shares Change (YoY)
75.83%58.35%0.02%33.27%53.71%95.36%
EPS (Basic)
-0.02-0.02-0.02-0.03-0.03-0.02
EPS (Diluted)
-0.02-0.02-0.02-0.03-0.03-0.02
Free Cash Flow
-13.39-6.89-5.13-5.31-4.42-2.92
Free Cash Flow Per Share
-0.03-0.02-0.03-0.03-0.03-0.03
Gross Margin
94.06%94.44%90.07%74.14%92.20%79.65%
Operating Margin
-166.25%-179.51%-102.64%-528.45%-183.72%-152.60%
Profit Margin
-158.45%-173.69%-101.14%-524.80%-183.74%-148.75%
Free Cash Flow Margin
-267.38%-182.04%-115.20%-446.19%-222.68%-190.52%
EBITDA
-8.32-6.78-4.56-6.28-3.64-2.34
EBITDA Margin
-166.19%-179.24%-102.40%--183.56%-152.56%
D&A For EBITDA
00.010.010.0100
EBIT
-8.32-6.79-4.57-6.29-3.64-2.34
EBIT Margin
-166.25%-179.51%-102.64%--183.72%-152.60%
Revenue as Reported
5.44.064.61.291.981.59
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.